---
tags: [course]
ctime: "2024-04-17T23:06:23"
mstime: "2024-04-17T23:06:23"

level: undergraduate
subject: 
university: mit
completion: closed
percentage: 0
prereq: "<ðŸŽ“Universities/MIT/7.012 Introductory Biology> , <ðŸŽ“Universities/MIT/18.02 Calculus> , and <ðŸŽ“Universities/MIT/3.091 Introduction to Solid,State Chemistry>"
coreq: "None."
---

catalog [20.102](http://student.mit.edu/catalog/m20a.html#20.102), [20.215](http://student.mit.edu/catalog/m20a.html#20.215)

<span style="display: block; padding: 15px; background-color: rgb(100, 100, 100, 0.2);"><font id="m_prereq2023_0" style="display: block; font-family: Arial, sans-serif; font-weight: bold; padding: 5px">Prerequisites</font><br><span id="prereq2023_0">[[ðŸŽ“Universities/MIT/7.012 Introductory Biology | B.TEMP]] , [[ðŸŽ“Universities/MIT/18.02 Calculus | CII.TEMP]] , and [[ðŸŽ“Universities/MIT/3.091 Introduction to Solid,State Chemistry | C.TEMP]]</span></span>
<span style="display: block; padding: 15px; background-color: rgb(100, 100, 100, 0.2);"><font id="m_coreq2023_0" style="display: block; font-family: Arial, sans-serif; font-weight: bold; padding: 5px">Corequisites</font><br><span id="coreq2023_0">None.</span></span>

<font style="">Description:</font>
<font style="color: grey; font-size: 0.8rem;">Metakaryotic stem cells of organogenesis, wound healing, and the pathogenic lesions of cancers and atherosclerotic plaques. Metakaryotic cell resistance to x-ray- and chemo-therapies. Common drug treatment protocols lethal to metakaryotic cancer stem cells <i>in vivo</i> first clinical trial against pancreatic cancer. Application of a hypermutable/mutator stem cell model to the age-specific mortality from clonal diseases, and the expected responses to metakaryocidal drugs in attempted cure and prevention of tumors or atherosclerotic plaques. Students taking 20.215 responsible for <i>de novo</i> computer modeling.</font>



---

<< HELLO, WORLD >>
